1996
DOI: 10.1002/(sici)1099-1557(199609)5:5<285::aid-pds236>3.0.co;2-t
|Get access via publisher |Summarize |Cite
Could Preferential Prescribing and Referral Behaviour of Physicians Explain the Elevated Thrombosis Risk Found to be Associated with Third Generation Oral Contraceptives?
Search citation statements
Paper Sections
Select...
36
0
0
0
Citation Types
0
6
0
0
Year Published
1996
2021
Publication Types
Select...
32
3
1
Relationship
1
35
Authors
Journals
Cited by 36 publications
(6 citation statements)
References 1 publication
0
6
0
0
“…A number of case-control studies demonstrated that OCs containing the third-generation progestogens further increased the risk of VTE 1.5-to 3-fold as compared to OCs containing the second-generation progestogen levonorgestrel. 23,[31][32][33][34] The results of several analyses and meta-analyses concluded that there is a real, definite but small difference in the risk between the second-and third-generation OCs. Cyproterone acetate and drospirenone-containing OCs seem to confer the same risk as the third-generation OCs.…”
Section: Oral Contraceptivesmentioning
confidence: 99%
“…A number of case-control studies demonstrated that OCs containing the third-generation progestogens further increased the risk of VTE 1.5-to 3-fold as compared to OCs containing the second-generation progestogen levonorgestrel. 23,[31][32][33][34] The results of several analyses and meta-analyses concluded that there is a real, definite but small difference in the risk between the second-and third-generation OCs. Cyproterone acetate and drospirenone-containing OCs seem to confer the same risk as the third-generation OCs.…”
Section: Oral Contraceptivesmentioning
confidence: 99%
“…A survey of German physicians showed an increased likelihood to prescribe a third-generation pill to high-risk patients and also to refer women using third-generation pills for diagnostic work-up for DVT even if symptoms were mild or nonspecific. 42 A Dutch study found that women using other cardiovascular medications were more likely to have been prescribed thirdgeneration than second-generation pills. 43 A large prospective European cohort study showed preferential prescription of DRSP products in obese women and in women with preexisting arrhythmia, which is another risk factor for clot formation.…”
Section: Prescribing Effectmentioning
confidence: 99%
